Tiziana Life Sciences Ltd
TLSA · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $92 | $38 | $46 | $29 |
| - Cash | $7 | $4 | $1 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $85 | $34 | $45 | $28 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$6 | -$9 | -$16 | -$9 |
| % Margin | – | – | – | – |
| Net Income | -$6 | -$7 | -$9 | -$9 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.096 | -0.13 | -0.18 | -0.18 |
| % Growth | 25.8% | 27.8% | 0% | – |
| Operating Cash Flow | -$7 | -$2 | $0 | -$3 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$7 | -$2 | $0 | -$3 |